Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
MediGene granted Galderma European rights to Oracea doxycycline, which the EC approved to treat rosacea last week. MediGene, which announced in June that it would exit its dermatology business, will ...